Trials / Unknown
UnknownNCT05109676
Monitoring of Progesterone Administered in Infertile Patients During a Cycle of Frozen Embryo Transfer.
Monitoring of Progesterone Administered in Infertile Patients During a Cycle of Frozen Embryo Transfer: a Population Pharmacokinetic Study.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
During an In Vitro Fertilization (IVF) attempt, several embryos are obtained but not all of them can be transferred to the uterus in the same cycle due to the risk of multiple pregnancies. Thus, it is very common for these couples to benefit from cryopreservation. Patients scheduled for frozen embryo transfer (TEC) receive estrogen and progesterone replacement therapy to prepare the endometrium for implantation. Data from the literature recently showed that low progesterone on the day of embryo transfer was responsible for a significantly higher rate of implantation failure and miscarriage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire | A questionnaire will be offered to patients and identify the schedules of administration of progesterone, the day and time of blood samples taken as part of the care, the potential adverse events associated with this administration. |
Timeline
- Start date
- 2021-12-07
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2021-11-05
- Last updated
- 2022-11-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05109676. Inclusion in this directory is not an endorsement.